Free Trial
TSE:ACB

Aurora Cannabis Q2 2025 Earnings Results & Report

Aurora Cannabis logo
C$6.05 -0.06 (-0.98%)
As of 11:43 AM Eastern

Aurora Cannabis beat analyst earnings expectations in its Q2 2025 results, released November 6, 2024. The company reported EPS of C$0.05 versus the -C$0.30 consensus estimate.

Earnings Announcement Details

Quarter
Q2 2025
Report Date
Time
Before Market Opens

Aurora Cannabis EPS Results

Actual EPS
C$0.05
Consensus EPS
-C$0.30
Beat/Miss
Beat by +C$0.35
One Year Ago EPS
-C$0.70
EPS Beat Rate
4 of last 8 quarters

Aurora Cannabis Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

Aurora Cannabis Q2 2025 Earnings FAQ

Aurora Cannabis (TSE:ACB) reported earnings of C$0.05 per share for Q2 2025, beating the consensus estimate of -C$0.30. The report was announced on Wednesday, November 6, 2024.

Aurora Cannabis Earnings Headlines

The AI Infrastructure Play Kevin O'Leary Is Backing
Kevin O'Leary became a strategic investor in a NASDAQ-listed AI infrastructure company, calling it essentially a power company. The firm expects up to 190 MW of Nordic data center capacity approaching ready-for-service status by 2027-2028, as similar capacity has recently been valued at roughly $1.7 million to $2 million per MW annually. Google plans to invest $15 billion in Finland's AI infrastructure, with Cerebras also building a 165 MW facility nearby.tc pixel
Aurora Cannabis (TSE:ACB) Stock Jumps 15.6% - Still a Buy?
See More Aurora Cannabis Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Aurora Cannabis? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Aurora Cannabis and other key companies, straight to your email.

About Aurora Cannabis

Aurora is Opening the World to Cannabis ¿, serving both the medical and consumer markets across Canada, Europe, Australia and New Zealand. Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis, dedicated to helping people improve their lives. The Company's adult-use brand portfolio includes Drift , San Raf , Daily Special ¿, Tasty's ¿, Being and Greybeard . Medical cannabis brands include MedReleaf , CanniMed , Aurora and Whistler Medical Marijuana Corporation , as well as international brands, Pedanios , IndiMed ¿ and CraftPlant ¿. Aurora also has a controlling interest in Bevo Farms Ltd., North America's leading supplier of propagated agricultural plants. Driven by science and innovation, and with a focus on high-quality cannabis products, Aurora's brands continue to break through as industry leaders in the medical, wellness and adult recreational markets wherever they are launched.

View Aurora Cannabis Profile